Advanced Wound Care and Closure Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

The advanced wound care and closure market was valued for $19.5 million in 2022 and is estimated to reach $32.9 million by 2032, exhibiting a CAGR of 5.4% from 2023 to 2032. The wound healing process is facilitated in two different ways, including traditional wound care (TWC) and advanced wound care (AWC). Advanced wound care and closures provide specialized treatment for chronic wounds that have not significantly healed during the conventional treatment. Thus, advanced wound care is developing as a standard solution for treating chronic wounds. These products offer various advantages over traditional wound care products including protection of wound from exogenous infection, maintain hydrated environment, and rapid healing of the wound. The advanced wound care products include advanced antimicrobial dressings, skin substitutes, negative pressure wound therapy, surgical sealant, topical tissue adhesives, and others.

The advanced wound care and closures market growth is significantly driven by increase in incidences of chronic wounds, surge in awareness about wound care, and rise in geriatric population. Chronic wounds such as traumatic wounds, venous ulcers, pressure ulcers, and others caused due to various medical conditions such as diabetes, and surgeries require long time for healing. To increase the healing process of chronic wounds, the advanced wound care and closure products are majorly used over the traditional wound care products. For instance, according to Australian Medical Association (AMA), 2023 report, about 450,000 Australians currently live with a chronic wound. In Addition, according to Healogics, LLC 2021, nearly 7 million Americans are living with chronic wound. Thus, rise in incidence of chronic wound drives the adoption of advanced wound care and closures.

Furthermore, surge in awareness about chronic wounds and their associated complications among the general population has increased the demand for advanced wound care solutions. Awareness campaigns, educational seminars, and training programs emphasize the benefits of using advanced wound care products over traditional methods. For instance, Wound Care Awareness Week organized by the Healogics, LLC., focuses on the growing need for wound care. In addition, Kisaco Research has organized the Advanced Wound Care Summit Europe in November 2023. This event is dedicated to advancing cutting-edge wound care products and will emphasize on the needs of industry.

Moreover, growing prevalence of chronic wounds with an ageing population and increasing rates of diseases such as diabetes and heart disease further propel the demand for advanced wound care and closures, which, in turn, drives the market growth.

However, advanced wound care products are more expensive than traditional wound care products. Thus, the high cost of advanced wound care products limits their adoption in the market. Furthermore, stringent regulations for manufacturing of advanced wound care dressing and devices act as a restraint to the market. However, development and launch of advanced products for wound management and surge in technological advancements are expected to create lucrative opportunities for the market growth during the forecast period.

The advance wound care and closures market is segmented on the basis of type, application, end user, and region. On the basis of type, the market is bifurcated into advanced wound closures and advanced wound care. The advanced wound closures segment is further classified into hemostatic and sealing agents, topical tissue adhesive, and wound closure devices. The advanced wound care segment is further classified into moist wound dressings, active wound care, and therapy devices. By application, the market is classified into burns, ulcers, and others. The ulcers segment is further divided into pressure ulcers, diabetic ulcers, and venous ulcers. Depending on end user, the market is classified into hospitals, clinic and nursing homes, and others.

Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global advanced wound care and closures market are 3M Company, B. Braun SE, Baxter International Inc., Coloplast, Convatec Group plc, Essity Aktiebolag AB, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Medtronic plc, and Smith and Nephew plc. Key players operating in the market have adopted product launch, acquisition, and agreement as key strategies to expand their market share and product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the advanced wound care and closure market analysis from 2022 to 2032 to identify the prevailing advanced wound care and closure market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the advanced wound care and closure market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global advanced wound care and closure market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Application

Burns
Ulcers
- Type
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Ulcers
Others

By End User

Hospitals
Clinics and Nursing Homes
Others

By Type

Advanced Wound Closures
- Advanced Wound Closures
- Hemostatic and Sealing Agent
- Topical Tissue Adhesive
- Wound Closure Devices
Advanced Wound Care
- Advanced Wound Care
- Moist Wound Dressings
- Active Wound Care

Type

Therapy Devices

Therapy Devices

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Integra LifeSciences Holdings Corporation
Essity Aktiebolag AB
Coloplast
Medtronic plc
Baxter International Inc.
3M Company
B. Braun SE
Johnson & Johnson
Convatec Group plc
Smith and Nephew plc.

Product Code: A00024

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. High bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in Incidences of chronic wounds
  - 3.4.1.2. Technological advancements in wound care management products
  - 3.4.1.3. Increase in number of surgical procedures
- 3.4.2. Restraints
  - 3.4.2.1. High cost of advanced wound care and closures
- 3.4.3. Opportunities
  - 3.4.3.1. Rise in new product launches

CHAPTER 4: ADVANCED WOUND CARE AND CLOSURE MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Advanced Wound Closures
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Advanced Wound Closures Advanced Wound Care and Closure Market by Advanced Wound Closures
4.3. Advanced Wound Care
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Advanced Wound Care Advanced Wound Care and Closure Market by Advanced Wound Care
  - 4.3.4.1. Active Wound Care Advanced Wound Care and Closure Market by Type
  - 4.3.4.2. Therapy Devices Advanced Wound Care and Closure Market by Therapy Devices

CHAPTER 5: ADVANCED WOUND CARE AND CLOSURE MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Burns
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Ulcers
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.3.4. Ulcers Advanced Wound Care and Closure Market by Type
5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: ADVANCED WOUND CARE AND CLOSURE MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Clinics and Nursing Homes
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: ADVANCED WOUND CARE AND CLOSURE MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Type
  - 7.2.5.1.2. Market size and forecast, by Application
  - 7.2.5.1.3. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Type
  - 7.2.5.2.2. Market size and forecast, by Application
  - 7.2.5.2.3. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Type
  - 7.2.5.3.2. Market size and forecast, by Application
  - 7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Type
  - 7.3.5.1.2. Market size and forecast, by Application
  - 7.3.5.1.3. Market size and forecast, by End User
  - 7.3.5.2. France
  - 7.3.5.2.1. Market size and forecast, by Type
  - 7.3.5.2.2. Market size and forecast, by Application
  - 7.3.5.2.3. Market size and forecast, by End User
  - 7.3.5.3. UK
  - 7.3.5.3.1. Market size and forecast, by Type
  - 7.3.5.3.2. Market size and forecast, by Application
  - 7.3.5.3.3. Market size and forecast, by End User
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Market size and forecast, by Type
  - 7.3.5.4.2. Market size and forecast, by Application
  - 7.3.5.4.3. Market size and forecast, by End User
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Market size and forecast, by Type
  - 7.3.5.5.2. Market size and forecast, by Application
  - 7.3.5.5.3. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Type
  - 7.3.5.6.2. Market size and forecast, by Application
  - 7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Market size and forecast, by Type
  - 7.4.5.1.2. Market size and forecast, by Application
  - 7.4.5.1.3. Market size and forecast, by End User
  - 7.4.5.2. China
  - 7.4.5.2.1. Market size and forecast, by Type
  - 7.4.5.2.2. Market size and forecast, by Application
  - 7.4.5.2.3. Market size and forecast, by End User
  - 7.4.5.3. India
  - 7.4.5.3.1. Market size and forecast, by Type
  - 7.4.5.3.2. Market size and forecast, by Application
  - 7.4.5.3.3. Market size and forecast, by End User
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Market size and forecast, by Type
  - 7.4.5.4.2. Market size and forecast, by Application
  - 7.4.5.4.3. Market size and forecast, by End User
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Market size and forecast, by Type
  - 7.4.5.5.2. Market size and forecast, by Application
  - 7.4.5.5.3. Market size and forecast, by End User
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Type
  - 7.4.5.6.2. Market size and forecast, by Application
  - 7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Type
  - 7.5.5.1.2. Market size and forecast, by Application
  - 7.5.5.1.3. Market size and forecast, by End User
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Market size and forecast, by Type
  - 7.5.5.2.2. Market size and forecast, by Application
  - 7.5.5.2.3. Market size and forecast, by End User
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Market size and forecast, by Type
  - 7.5.5.3.2. Market size and forecast, by Application
  - 7.5.5.3.3. Market size and forecast, by End User
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Market size and forecast, by Type
  - 7.5.5.4.2. Market size and forecast, by Application
  - 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Convatec Group plc
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
9.2. Integra LifeSciences Holdings Corporation
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
9.3. Essity Aktiebolag AB
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
9.4. Smith and Nephew plc.
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
9.5. B. Braun SE
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
9.6. Coloplast
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
9.7. Johnson & Johnson
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
9.8. Medtronic plc
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
9.9. Baxter International Inc.
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
9.10. 3M Company
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance